Total Payments
$128,640
2024 Payments
$6,125
Companies
35
Transactions
687
Medicare Patients
815
Medicare Billing
$97,418
Payment Breakdown by Category
Other$96,445 (75.0%)
Travel$20,778 (16.2%)
Food & Beverage$10,108 (7.9%)
Consulting$1,210 (0.9%)
Education$99.34 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $96,445 | 53 | 75.0% |
| Travel and Lodging | $20,778 | 57 | 16.2% |
| Food and Beverage | $10,108 | 566 | 7.9% |
| Consulting Fee | $1,210 | 1 | 0.9% |
| Education | $99.34 | 10 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Gilead Sciences, Inc. | $123,646 | 331 | $0 (2024) |
| ViiV Healthcare Company | $1,295 | 106 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $565.97 | 38 | $0 (2024) |
| GlaxoSmithKline, LLC. | $423.88 | 32 | $0 (2024) |
| Janssen Biotech, Inc. | $361.08 | 28 | $0 (2019) |
| PFIZER INC. | $313.34 | 26 | $0 (2019) |
| Novo Nordisk Inc | $264.42 | 16 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $235.68 | 21 | $0 (2019) |
| ABBVIE INC. | $219.06 | 11 | $0 (2024) |
| EMD Serono, Inc. | $158.57 | 8 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $6,125 | 69 | Gilead Sciences, Inc. ($5,493) |
| 2023 | $16,984 | 90 | Gilead Sciences, Inc. ($16,352) |
| 2022 | $12,901 | 33 | Gilead Sciences, Inc. ($12,901) |
| 2021 | $9,245 | 34 | Gilead Sciences, Inc. ($9,135) |
| 2020 | $8,868 | 27 | Gilead Sciences, Inc. ($8,814) |
| 2019 | $22,109 | 117 | Gilead Sciences, Inc. ($21,216) |
| 2018 | $24,291 | 163 | Gilead Sciences, Inc. ($23,035) |
| 2017 | $28,116 | 154 | Gilead Sciences Inc ($26,700) |
All Payment Transactions
687 individual payment records from CMS Open Payments — Page 1 of 28
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $6.85 | General |
| 12/11/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $400.00 | General |
| Category: HIV | ||||||
| 12/11/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.39 | General |
| Category: Diabetes | ||||||
| 12/11/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $5.22 | General |
| Category: HIV | ||||||
| 12/04/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: Respiratory | ||||||
| 11/26/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: HIV | ||||||
| 11/21/2024 | ViiV Healthcare Company | CABENUVA (Biological) | Food and Beverage | In-kind items and services | $12.19 | General |
| Category: HIV | ||||||
| 11/21/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $6.59 | General |
| 11/15/2024 | Gilead Sciences, Inc. | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,980.00 | General |
| 11/13/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $115.53 | General |
| 11/12/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | In-kind items and services | $3.37 | General |
| Category: HIV | ||||||
| 11/07/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $6.51 | General |
| 11/01/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $15.74 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $7.08 | General |
| 10/30/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.92 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: Obesity | ||||||
| 10/21/2024 | Abbott Laboratories | CARDIOMEMS (Device) | Food and Beverage | In-kind items and services | $27.99 | General |
| Category: Heart Failure | ||||||
| 10/16/2024 | ViiV Healthcare Company | APRETUDE (Biological) | Food and Beverage | In-kind items and services | $5.49 | General |
| Category: HIV | ||||||
| 10/09/2024 | ViiV Healthcare Company | RUKOBIA (Drug) | Food and Beverage | In-kind items and services | $2.90 | General |
| Category: HIV | ||||||
| 10/04/2024 | Antares Pharma, Inc. | XYOSTED (Drug) | Food and Beverage | In-kind items and services | $14.57 | General |
| Category: TESTOSTERONE REPLACEMENT THERAPY | ||||||
| 09/26/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $11.84 | General |
| 09/25/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: RESPIRATORY | ||||||
| 09/25/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $5.36 | General |
| 09/11/2024 | Gilead Sciences, Inc. | — | Food and Beverage | In-kind items and services | $19.10 | General |
| 09/10/2024 | Gilead Sciences, Inc. | Biktarvy (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,980.00 | General |
| Category: HIV | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 8 | 315 | 563 | $122,853 | $42,206 |
| 2022 | 3 | 108 | 243 | $30,193 | $17,176 |
| 2021 | 4 | 134 | 282 | $31,237 | $17,681 |
| 2020 | 8 | 258 | 364 | $41,543 | $20,355 |
Total Patients
815
Total Services
1,452
Medicare Billing
$97,418
Procedure Codes
23
All Medicare Procedures & Services
23 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 94 | 310 | $79,360 | $28,712 | 36.2% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 46 | 46 | $20,332 | $5,428 | 26.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 33 | 39 | $14,079 | $4,016 | 28.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 24 | 33 | $6,006 | $2,304 | 38.4% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 27 | 27 | $918.00 | $808.38 | 88.1% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2023 | 27 | 27 | $1,080 | $591.30 | 54.8% |
| 81002 | Urinalysis, manual test | Office | 2023 | 50 | 67 | $938.00 | $228.47 | 24.4% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 14 | 14 | $140.00 | $117.60 | 84.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 60 | 195 | $28,513 | $15,950 | 55.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2022 | 27 | 27 | $945.00 | $782.46 | 82.8% |
| 90686 | Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage | Office | 2022 | 21 | 21 | $735.00 | $442.89 | 60.3% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 70 | 193 | $28,220 | $16,346 | 57.9% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage, quadrivalent, preservation free | Office | 2021 | 25 | 26 | $910.00 | $532.83 | 58.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2021 | 23 | 25 | $875.00 | $419.46 | 47.9% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2021 | 16 | 38 | $1,231 | $382.84 | 31.1% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 82 | 169 | $24,711 | $11,523 | 46.6% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 36 | 36 | $7,063 | $3,382 | 47.9% |
| 90732 | Vaccine for pneumococcal polysaccharide for injection beneath the skin or into muscle, patient 2 years or older | Office | 2020 | 21 | 21 | $3,409 | $2,510 | 73.6% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 17 | 24 | $2,430 | $1,102 | 45.4% |
| 90686 | Vaccine for influenza for administration into muscle, 0.5 ml dosage | Office | 2020 | 32 | 32 | $1,120 | $626.56 | 55.9% |
| G0008 | Administration of influenza virus vaccine | Office | 2020 | 32 | 32 | $1,120 | $528.96 | 47.2% |
| G0009 | Administration of pneumococcal vaccine | Office | 2020 | 25 | 27 | $945.00 | $445.65 | 47.2% |
| 96372 | Injection beneath the skin or into muscle for therapy, diagnosis, or prevention | Office | 2020 | 13 | 23 | $745.20 | $237.22 | 31.8% |
About Dr. William Summers, MD
Dr. William Summers, MD is a Infectious Disease healthcare provider based in Saint Louis, Missouri. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1265471650.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Summers, MD has received a total of $128,640 in payments from pharmaceutical and medical device companies, with $6,125 received in 2024. These payments were reported across 687 transactions from 35 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($96,445).
As a Medicare-enrolled provider, Summers has provided services to 815 Medicare beneficiaries, totaling 1,452 services with total Medicare billing of $97,418. Data is available for 4 years (2020–2023), covering 23 distinct procedure/service records.
Ad
Practice Information
- Specialty Infectious Disease
- Other Specialties Infectious Disease, Internal Medicine
- Location Saint Louis, MO
- Active Since 06/04/2006
- Last Updated 05/31/2024
- Taxonomy Code 207RI0200X
- Entity Type Individual
- NPI Number 1265471650
Products in Payments
- Biktarvy (Drug) $48,919
- Genvoya (Drug) $12,612
- Sunlenca (Drug) $8,233
- DOVATO (Drug) $593.67
- PREZCOBIX (Drug) $313.40
- FARXIGA (Drug) $288.36
- TRELEGY ELLIPTA (Drug) $236.82
- APRETUDE (Biological) $177.96
- Symtuza (Drug) $176.41
- JULUCA (Drug) $159.06
- Mavyret (Drug) $135.34
- CABENUVA (Biological) $129.93
- Descovy (Drug) $123.35
- ANORO (Drug) $114.87
- ISENTRESS (Drug) $114.41
- BREZTRI (Drug) $111.19
- JANUVIA (Drug) $108.69
- TIVICAY (Drug) $108.24
- TRIUMEQ (Drug) $107.76
- XARELTO (Drug) $104.41
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Infectious Disease Doctors in Saint Louis
Robert Belshe, Md, MD
Infectious Disease — Payments: $421,832
Infectious Disease $421,832
Dr. Erik Dubberke, Md, MD
Infectious Disease — Payments: $161,161
Infectious Disease $161,161
Dr. Rupa Patel, Md, MD
Infectious Disease — Payments: $116,585
Infectious Disease $116,585
Dr. William Powderly, Md, MD
Infectious Disease — Payments: $52,771
Infectious Disease $52,771
Dr. Michael Diamond, Md, MD
Infectious Disease — Payments: $44,261
Infectious Disease $44,261
Dr. Andrej Spec, Md, MD
Infectious Disease — Payments: $24,246
Infectious Disease $24,246